Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001789769-24-000038
Filing Date
2024-03-21
Accepted
2024-03-21 17:15:12
Documents
7
Effectiveness Date
2024-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 s-8.htm S-8 50375
2 EX-FILING FEES instil-formsx8x2024everg.htm EX-FILING FEES 4575
3 EX-5.1 instil-formsx82024evergr.htm EX-5.1 4966
4 EX-23.1 s-8ex231consentofdeloittet.htm EX-23.1 1701
5 GRAPHIC instil-formsx82024evergr001.jpg GRAPHIC 240378
6 GRAPHIC instil-formsx82024evergr002.jpg GRAPHIC 61557
7 GRAPHIC instil-formsx8x2024everg001.jpg GRAPHIC 215845
  Complete submission text file 0001789769-24-000038.txt   776077
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278154 | Film No.: 24772319
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)